Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiangqin Granules for Influenza (Wind-Heat Pattern) – Phase II Randomized Double-Blind Placebo-Controlled Trial
CTR20244940Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing Qiangqin Granules with Placebo (Qiangqin Granules simulator) (2 arms). Primary endpoints: Adverse events / adverse reactions, Disease remission time and 9 more. Started Dec 2024; status: completed.
02
Drugs
Qiangqin
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20244940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244940.